During the past decade, CenterMed Lublin NZOZ conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CenterMed Lublin NZOZ" are "Type 2 Diabetes Mellitus" (2 trials), "Heart Failure" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "CenterMed Lublin NZOZ" in a lesser frequency.

Most popular intervention types in "CenterMed Lublin NZOZ" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (3 trials), "Placebo" (2 trials), "Dulaglutide" (1 trials), "Insulin Degludec" (1 trials) and "Insulin Efsitora Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "CenterMed Lublin NZOZ" are 5 trials for "All" genders.

Currently, there are NaN active trials in "CenterMed Lublin NZOZ". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CenterMed Lublin NZOZ, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CenterMed Lublin NZOZ, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".